321 related articles for article (PubMed ID: 36821979)
1. Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.
Shi Z; Pan Y; Yan Z; Ding S; Hu H; Wei Y; Luo D; Xu Y; Zhu Q; Li Y
Mult Scler Relat Disord; 2023 Mar; 71():104572. PubMed ID: 36821979
[TBL] [Abstract][Full Text] [Related]
2. The heterogeneity of tissue destruction between iron rim lesions and non-iron rim lesions in multiple sclerosis: A diffusion MRI study.
Hu H; Ye L; Ding S; Zhu Q; Yan Z; Chen X; Chen G; Feng X; Li Q; Li Y
Mult Scler Relat Disord; 2022 Oct; 66():104070. PubMed ID: 35914471
[TBL] [Abstract][Full Text] [Related]
3. The Application of Diffusion Kurtosis Imaging on the Heterogeneous White Matter in Relapsing-Remitting Multiple Sclerosis.
Zhu Q; Zheng Q; Luo D; Peng Y; Yan Z; Wang X; Chen X; Li Y
Front Neurosci; 2022; 16():849425. PubMed ID: 35360163
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging.
Li HQ; Yin B; Quan C; Geng DY; Yu H; Bao YF; Liu J; Li YX
BMC Neurol; 2018 Aug; 18(1):108. PubMed ID: 30086721
[TBL] [Abstract][Full Text] [Related]
5. U-fiber diffusion kurtosis and susceptibility characteristics in relapsing-remitting multiple sclerosis may be related to cognitive deficits and neurodegeneration.
Luo D; Peng Y; Zhu Q; Zheng Q; Luo Q; Han Y; Chen X; Li Y
Eur Radiol; 2024 Mar; 34(3):1422-1433. PubMed ID: 37658142
[TBL] [Abstract][Full Text] [Related]
6. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
[TBL] [Abstract][Full Text] [Related]
7. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging.
Caranova M; Soares JF; Batista S; Castelo-Branco M; Duarte JV
Magn Reson Imaging; 2023 Dec; 104():61-71. PubMed ID: 37775062
[TBL] [Abstract][Full Text] [Related]
9. Role of white matter in cognitive impairment among relapsing remitting multiple sclerosis patients.
Elkhooly M; Bao F; Raghib M; Millis S; Bernitsas E
Mult Scler Relat Disord; 2023 Nov; 79():105030. PubMed ID: 37837669
[TBL] [Abstract][Full Text] [Related]
10. Microstructural white matter alterations in Alzheimer's disease and amnestic mild cognitive impairment and its diagnostic value based on diffusion kurtosis imaging: a tract-based spatial statistics study.
Li T; Zhang Y; Fu X; Zhang X; Luo Y; Ni H
Brain Imaging Behav; 2022 Feb; 16(1):31-42. PubMed ID: 33895943
[TBL] [Abstract][Full Text] [Related]
11. Microstructural white matter abnormalities in overactive bladder syndrome evaluation with diffusion kurtosis imaging tract-based spatial statistics analysis.
Zuo L; Tian T; Wang B; Gu H; Wang S
World J Urol; 2024 Jan; 42(1):36. PubMed ID: 38217714
[TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS.
Alshehri A; Koussis N; Al-Iedani O; Arm J; Khormi I; Lea S; Lea R; Ramadan S; Lechner-Scott J
Eur J Radiol; 2024 Jan; 170():111207. PubMed ID: 37988961
[TBL] [Abstract][Full Text] [Related]
13. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
[TBL] [Abstract][Full Text] [Related]
14. Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate.
Alshehri A; Al-Iedani O; Koussis N; Khormi I; Lea R; Lechner-Scott J; Ramadan S
Neuroradiol J; 2023 Aug; 36(4):388-396. PubMed ID: 36395524
[TBL] [Abstract][Full Text] [Related]
15. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study.
Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH
Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524
[TBL] [Abstract][Full Text] [Related]
16. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
[TBL] [Abstract][Full Text] [Related]
17. Comparative Evaluation of Diffusion Kurtosis Imaging and Diffusion Tensor Imaging in Detecting Cerebral Microstructural Changes in Alzheimer Disease.
Raj S; Vyas S; Modi M; Garg G; Singh P; Kumar A; Kamal Ahuja C; Goyal MK; Govind V
Acad Radiol; 2022 Mar; 29 Suppl 3():S63-S70. PubMed ID: 33612351
[TBL] [Abstract][Full Text] [Related]
18. Diffusion kurtosis imaging as a neuroimaging biomarker in patients with carbon monoxide intoxication.
Lee JJ; Chang WN; Hsu JL; Huang CW; Chang YT; Hsu SW; Huang SH; Lee CC; Lien CY; Chang CC
Neurotoxicology; 2018 Sep; 68():38-46. PubMed ID: 30017424
[TBL] [Abstract][Full Text] [Related]
19. Increased cortical lesion load contributed to pathological changes beyond focal lesion in cortical gray matter of multiple sclerosis: a diffusion kurtosis imaging analysis.
Zhu Q; Yan Z; Shi Z; Luo D; Ding S; Chen X; Li Y
Cereb Cortex; 2023 Oct; 33(21):10867-10876. PubMed ID: 37718158
[TBL] [Abstract][Full Text] [Related]
20. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
